Cas 1246853-14-4,(1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol

1246853-14-4

Post Buying Request

Basic information

Product Name: (1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol
Synonyms: (1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol
CAS NO:1246853-14-4
Molecular Formula:
Molecular Weight: 333.471
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol(CAS DataBase Reference)
NIST Chemistry Reference: (1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol(1246853-14-4)
EPA Substance Registry System: (1S,2R,5R,8R,8aR)-5-(2-(4-tert-butylphenyl)ethyl)octahydroindolizine-1,2,8-triol(1246853-14-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1246853-14-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1246853-14-4 Suppliers

Recommended suppliers

1246853-14-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1246853-14-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,8,5 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1246853-14:
(9*1)+(8*2)+(7*4)+(6*6)+(5*8)+(4*5)+(3*3)+(2*1)+(1*4)=164
164 % 10 = 4
So 1246853-14-4 is a valid CAS Registry Number.

1246853-14-4Upstream product

943-27-1 4'-t-butylacetophenone

1246853-14-4Downstream Products

1246853-14-4Relevant academic research and scientific papers

Structural investigation of the binding of 5-substituted swainsonine analogues to golgi α-mannosidase II

Kuntz, Douglas A.,Nakayama, Shinichi,Shea, Kayla,Hori, Hitoshi,Uto, Yoshihiro,Nagasawa, Hideko,Rose, David R.

, p. 673 - 680 (2010)

Golgi α-mannosidase II (GMII) is a key enzyme in the N-glycosylation pathway and is a potential target for cancer chemotherapy. The natural product swainsonine is a potent inhibitor of GMII. In this paper we characterize the binding of 5α-substituted swai

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1246853-14-4